Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma

Surgery (United States)

Volumn 154, Issue 5, 2013, Pages 1053-1060

  Kaido, Toshimi ^a   Ogawa, Kohei ^a   Mori, Akira ^a   Fujimoto, Yasuhiro ^a   Ito, Takashi ^a   Tomiyama, Koji ^a   Takada, Yasutsugu ^b   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHEMOEMBOLIZATION; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; INTENTION TO TREAT ANALYSIS; KYOTO CRITERIA; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR INVASION; CARCINOMA, HEPATOCELLULAR; JAPAN; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; VALIDATION STUDY; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84886092805     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.04.056     Document Type: Article

References (25)

1. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
2. F.Y. Yao, L. Xiao, N.M. Bass, R. Kerlan, N.L. Ascher, and J.P. Roberts Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging Am J Transplant 7 2007 2587 2596
3. V. Mazzaferro, J.M. Llovet, R. Miceli, S. Bhoori, M. Schiavo, and L. Mariani Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
4. Y. Sugawara, S. Tamura, and M. Makuuchi Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series Dig Dis 25 2007 310 312
5. C. Toso, S. Asthana, D.L. Bigam, A.M. Shapiro, and N.M. Kneteman Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database Hepatology 49 2009 832 838
6. S.S. Zheng, X. Xu, J. Wu, J. Chen, W.L. Wang, and M. Zhang Liver transplantation for hepatocellular carcinoma: Hangzhou experiences Transplantation 85 2008 1726 1732
7. Y. Takada, T. Ito, M. Ueda, S. Sakamoto, H. Haga, and Y. Maetani Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria Dig Dis 25 2007 299 302
8. A.I. Gomaa, S.A. Khan, E.L. Leen, I. Waked, and S.D. Taylor-Robinson Diagnosis of hepatocellular carcinoma World J Gastroenterol 15 2009 1301 1314
9. K. Yamamoto, H. Imamura, Y. Matsuyama, K. Hasegawa, Y. Beck, and Y. Sugawara Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy Ann Surg Oncol 16 2009 2795 2804
10. H. Miyaaki, O. Nakashima, M. Kurogi, K. Eguchi, and M. Kojiro Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma J Gastroenterol 42 2007 962 968
11. S. Nagaoka, H. Yatsuhashi, H. Hamada, K. Yano, T. Matsumoto, and M. Daikoku The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma Cancer 98 2003 2671 2677
12. M. Fujiki, Y. Takada, Y. Ogura, F. Oike, T. Kaido, and S. Teramukai Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocelluar carcinoma Am J Transplant 9 2009 2362 2371
13. Y. Takada, T. Ito, M. Ueda, S. Sakamoto, H. Haga, and Y. Maetani Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma Liver Transpl 12 2006 912 919
14. D. Morioka, H. Egawa, M. Kasahara, T. Ito, H. Haga, and Y. Takada Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases Ann Surg 245 2007 315 325
15. Y. Inomata, S. Uemoto, K. Asonuma, and H. Egawa Right lobe graft in living donor liver transplantation Transplantation 69 2000 258 264
16. T. Ito, T. Kiuchi, H. Egawa, S. Kaihara, F. Oike, and Y. Ogura Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases Transplantation 76 2003 158 163
17. Y. Inomata, K. Tanaka, H. Egawa, S. Uemoto, N. Ozaki, and H. Okajima The evolution of immunosuppression with FK 506 in pediatric living related liver transplantation Transplantation 61 1996 247 252
18. C. Toso, S. Cader, A. Mentha-Dugerdil, G. Meeberg, P. Majno, and I. Morard Factors predicting survival after post-transplant hepatocellular carcinoma recurrence J Hepatobiliary Pancreat Sci 20 2013 342 347
19. T. Suehiro, K. Sugimachi, T. Matsumata, H. Itasaka, A. Taketomi, and T. Maeda Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein Cancer 73 1994 2464 2471
20. Y. Koike, Y. Shiratori, S. Sato, S. Obi, T. Teratani, and M. Imamura Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients Cancer 91 2001 561 569
21. Y. Kim do, Y.H. Paik, S.H. Ahn, Y.J. Youn, J.W. Choi, and J.K. Kim PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection Oncology 72 Suppl 1 2007 52 57
22. T. Ito, Y. Takada, M. Ueda, H. Haga, Y. Maetani, and F. Oike Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation Liver Transpl 13 2007 1637 1644
23. H. Okuda, T. Nakanishi, K. Takatsu, A. Saito, N. Hayashi, and K. Takasaki Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma Cancer 88 2000 544 549
24. K. Shirabe, S. Itoh, T. Yoshizumi, Y. Soejima, A. Taketomi, and S. Aishima The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin J Surg Oncol 95 2007 235 240
25. J.A. Marrero, G.L. Su, W. Wei, D. Emick, H.S. Conjeevaram, and R.J. Fontana Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients Hepatology 37 2003 1114 1121